EPI Übernahme - Wir halten zusammen
| eröffnet am: | 02.05.17 18:21 von: | citus17 |
| neuester Beitrag: | 19.02.26 08:10 von: | timtom1011 |
| Anzahl Beiträge: | 15837 | |
| Leser gesamt: | 5152167 | |
| davon Heute: | 740 | |
bewertet mit 6 Sternen |
||
|
|
||
31.03.25 23:35
#15826
Mogli3
News von NDD
Big News from New Day Diagnostics!
We’re proud to announce the nationwide launch of ColoHealth our FDA-cleared blood test for colorectal cancer screening, now available for physician ordering across the U.S.
ColoHealth is a game-changer in early detection—simple, accurate, non-invasive—and empowers providers to offer patients a more accessible screening option.
Read the official press release to learn more: https://loom.ly/rvEjfw8
We’re proud to announce the nationwide launch of ColoHealth our FDA-cleared blood test for colorectal cancer screening, now available for physician ordering across the U.S.
ColoHealth is a game-changer in early detection—simple, accurate, non-invasive—and empowers providers to offer patients a more accessible screening option.
Read the official press release to learn more: https://loom.ly/rvEjfw8
21.07.25 22:13
#15830
Mogli3
News von NDD auf LinkedIn
NDD ist dran am next-gen Test der von Epigenomics übernommen wurde. Mal sehen…….
„At ADLM 2025, meet us at the Luminex booth ) where we’ll be talking about how the Luminex ELISA platform powers our work- from developing ColoPlex Plus a next-gen blood test for early colorectal cancer detection, to designing custom assays for diagnostics developers.
Through New Day Bioresearch, we offer contract research services that help bring your vision to life- from assay design to analytical validation.
If you're building a better test, let's talk.“
„At ADLM 2025, meet us at the Luminex booth ) where we’ll be talking about how the Luminex ELISA platform powers our work- from developing ColoPlex Plus a next-gen blood test for early colorectal cancer detection, to designing custom assays for diagnostics developers.
Through New Day Bioresearch, we offer contract research services that help bring your vision to life- from assay design to analytical validation.
If you're building a better test, let's talk.“
01.08.25 11:59
#15831
Mogli3
NDD macht ernst mit NextGen von Epigenomics
ColoHealth ist der alte Test von Epigenomics, ColoPlex Plus der neue Test NextGen von Epigenomics.
„Having a great showcase for ColoHealth and (coming soon!!) ColoPlexPLUS at Association for Diagnostics & Laboratory Medicine ADLM2025 with our amazing clinical oncology partner Luminex booth 1431!“
Bin dann mal gespannt wenn dieser neue Test auf den Markt kommt.
„Having a great showcase for ColoHealth and (coming soon!!) ColoPlexPLUS at Association for Diagnostics & Laboratory Medicine ADLM2025 with our amazing clinical oncology partner Luminex booth 1431!“
Bin dann mal gespannt wenn dieser neue Test auf den Markt kommt.
09.01.26 11:30
#15832
Mogli3
News zu Epi und NDD
Ein neuer Anlauf zur Durchführung der erforderlichen Studie für Zulassung NextGen mit Septin9.
Man weiß ja nie.
https://apnews.com/press-release/...source=Email&utm_medium=share
Man weiß ja nie.
https://apnews.com/press-release/...source=Email&utm_medium=share
09.02.26 16:50
#15834
Mogli3
News zu Septin9 von Epi
Zumindest der Test mit Septin9 lebt noch……
Our CEO Eric Mayer had a colonoscopy before age 40. Its in his blood. His immediate family member had a positive ColoHealth Direct blood test and detected polyps when their stool test was negative and missed those early stage lesions.
Early detection saves lives, especially as this disease hits us younger and younger.
Our ColoHealth Direct (mSEPT9) blood test, available NOW directly to patients and providers, has recently shown excellent early-onset CRC and polyp detection performance in younger cohorts according to a study by Dr. Loomans-Kropp with the National Cancer Institute’s Division of Cancer Prevention....time for us all to get screened!
Our CEO Eric Mayer had a colonoscopy before age 40. Its in his blood. His immediate family member had a positive ColoHealth Direct blood test and detected polyps when their stool test was negative and missed those early stage lesions.
Early detection saves lives, especially as this disease hits us younger and younger.
Our ColoHealth Direct (mSEPT9) blood test, available NOW directly to patients and providers, has recently shown excellent early-onset CRC and polyp detection performance in younger cohorts according to a study by Dr. Loomans-Kropp with the National Cancer Institute’s Division of Cancer Prevention....time for us all to get screened!
17.02.26 08:30
#15835
timtom1011
Oh
Guten Morgen
Shsut euch BID und ASk
Hier an ASk steht bei 7 Euro
Shsut euch BID und ASk
Hier an ASk steht bei 7 Euro
19.02.26 08:10
#15837
timtom1011
Guten Morgen
Das Phänomen, dass falsch geschriebene Wörter dennoch lesbar sind, beruht darauf, dass unser Gehirn Wörter als Ganzes erfasst und nicht Buchstabe für Buchstabe liest. Entscheidend ist meist nur, dass der erste und letzte Buchstabe korrekt sind.